Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Medicine (United States)

Volumn 96, Issue 9, 2017, Pages

  Golabi, Pegah ^a   Fazel, Sofie ^a   Otgonsuren, Munkhzul ^a   Sayiner, Mehmet ^a   Locklear, Cameron T ^b   Younossi, Zobair M ^a,b  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

hepatocellular carcinoma; liver transplantation; mortality; surgical resection

Indexed keywords

AGED; ALCOHOL LIVER DISEASE; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; DATA BASE; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; CANCER REGISTRY; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 85015942244     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005904     Document Type: Article

References (50)

1. WHO. World Cancer Report 2014-Available at: http://www.who.int/ mediacentre/factsheets/fs297/en. Accessed 2014.
2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-55.
3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76.
4. Stewart BW, Wild CPE. World Cancer Report 2014. International Agency for Research on Cancer, Lyon, France:2014.
5. SEER. SEER Stat Fact Sheets: Liver and Intrahepatic Bile Duct Cancer- 2015. Available at: http://seer.cancer.gov/statfacts/html/livibd.html Accessed 2015.
6. Demirelli S, Erkilic M, Oner AO, et al. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres. Nucl Med Commun 2015;36:340-9.
7. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.
8. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
9. CDC. Morbidity and Mortality Weekly Report [May 7, 2010/59 (17);517-520]-Hepatocellular Carcinoma, United States, 2001-2006, Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5917 a3.htm. Accessed 2010.
10. Seeff LB. Introduction: the burden of hepatocellular carcinoma. Gastroenterology 2004;127(5 suppl 1):S1-4.
11. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. 2008;National Cancer Institute, Bethesda, MD:Accessed from http://seer.cancer.gov/csr/1975-2005/.
12. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-23.
13. CLIPA new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751-5.
14. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011;15:223-43. vii-x.
15. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015;19:223-38.
16. Fitzmorris P, Shoreibah M, Anand BS, et al. Management of hepatocellular carcinoma. J Cancer Res Clin Oncol 2015;141:861-76.
17. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
18. Jarnagin WR. Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol 2010;17: 1226-33.
19. Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011;253:453-69.
20. Dhir M, Lyden ER, Smith LM, et al. Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford) 2012;14:635-45.
21. Squires MH3rd, Hanish SI, Fisher SB, et al. Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol 2014;109:533-41.
22. Teh SH, Christein J, Donohue J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005;9:1207-15. discussion 1215.
23. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
24. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403.
25. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200.
26. Graf D, Vallbohmer D, Knoefel WT, et al. Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med 2014;25:430-7.
27. Sogawa H, Shrager B, Jibara G, et al. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) 2012;15:134-41.
28. Dai Y, Li C, Wen TF, et al. Comparison of liver resection and transplantation for Child-Pugh A cirrhotic patient with very early hepatocellular carcinoma and portal hypertension. Pak J Med Sci 2014;30:996-1000.
29. Xu XS, Liu C, Qu K, et al. Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis. Hepatobiliary Pancreat Dis Int 2014;13:234-41.
30. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008;48(suppl 1):S20-37.
31. Probst A, Dang T, Bochud M, et al. Role of hepatitis C virus genotype 3 in liver fibrosis progression-a systematic review and meta-analysis. J Viral Hepat 2011;18:745-59.
32. Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003;98:2060-3.
33. Gurtsevitch VE. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc) 2008;73:504-13.
34. Davis GL, Dempster J, Meler JD, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) 2008;21:266-80.
35. Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009;10:1111-8.
36. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010;15(suppl 4):14-22.
37. Younossi ZM, Kanwal F, Saab S, et al. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther 2014;39:518-31.
38. Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 2015;62: 1723-30.
39. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9:524-30. e1; quiz e60.
40. Dai WC, Chan SC, Chok KS, et al. Good long term survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8cm in diameter. HPB (Oxford) 2014;16:749-57.
41. Song S, Moon HH, Lee S, et al. Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. Transplant Proc 2013;45:3041-6.
42. Ribero D, Curley SA, Imamura H, et al. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 2008;15:986-92.
43. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12:364-73.
44. Berry K, Ioannou GN. Are patients with Child's A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation? Am J Transplant 2012;12:706-17.
45. Groeschl RT, Clark Gamblin T, Turaga KK. Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: a strategy in the era of organ shortage. Ann Surg Oncol 2013;20: 2043-8.
46. Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol 2015;7:245-52.
47. Sapisochin G, Castells L, Dopazo C, et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol 2013;20: 1194-202.
48. Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 2012;99:1622-9.
49. Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer
50. O'Malley KJ, Cook KF, Price MD, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40(5 pt 2):1620-39.